Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, July 2011

Sort by: Newest first Oldest first A-Z Z-A

  • Drug management of ischaemic stroke Subscription

    1 JUL 2011

    A 74-year-old man was admitted to the stroke ward yesterday with rapid onset left-sided weakness, dysphasia and slurred speech. On reviewing his drug chart you see that he received alteplase shortly after admission, but he is not currently prescribed any regular medication.

  • Why The Journal has a different look Subscription

    1 JUL 2011 10:08

    Readers who are avid followers of The Pharmaceutical Journal or are particularly visually aware may be surprised that we are redesigning The Journal only a year after the previous version was introduced.

  • Angela Timoney

    Angela Timoney takes the helm at the Scottish Medicines Consortium

    1 JUL 2011 10:23

    The responsibility of deciding which medicines may be used within the NHS in Scotland came under the leadership of pharmacist Angela Timoney in May.

  • Child taking medicine

    Spin-off company set to win first paediatric-use marketing authorisation

    1 JUL 2011 10:40

    A spin-off company set up by The School of Pharmacy, University of London, is leading the way in bringing paediatric medicines onto the European market.

  • Duncan McRobbie

    Guy’s staff tender as social enterprise

    1 JUL 2011 11:05

    Staff at Guy’s and St Thomas’ NHS Foundation Trust have bid as a social enterprise for the hospital’s outpatient dispensing contract, which is currently out for tender. Duncan McRobbie, associate chief pharmacist for clinical services at the trust, told PJ Online that the decision to outsource the service was about saving VAT.

  • SPC changes (PJ, 2 July 2011)

    1 JUL 2011 11:56

    LucentisLucentis (ranibizumab; Novartis) is now indicated for the treatment of adults with visual impairment due to macular oedema secondary to retinalvein occlusion (branch or central). The dose recommendations are the same as for patients with diabetic macular oedema (PJ, 5 March 2011, p265). 

  • Prescription Products (Repaglinide)

    1 JUL 2011 11:58

    Repaglinide (Actavis)Repaglinide tablets are now available from Actavis. Net price: 30 x 0.5mg, £2.74; 90 x 0.5mg, £8.23; 30 x 1mg, £2.74; 90 x 1mg, £8.23; 90 x 2mg, £8.23.Repaglinide (Aspire)Repaglinide tablets are now available from Aspire Pharma. Net price: 90 x 0.5mg, £11.17; 90 x 1mg, £11.17; 90 x 2mg, £11.17.

  • Drug Tariff Updates (2 July 2011)

    1 JUL 2011 12:00

    BetahistineThe Department of Health and the National Assembly for Wales have agreed to allow “no cheaper stock obtainable” (NCSO) endorsements for betahistine tablets 8mg for June prescriptions. 

  • Supply Issues - Stelazine (2 July 2011)

    1 JUL 2011 12:03

    Stelazine Stelazine (trifluoperazine hydrochloride) syrup 1mg/5ml  is now available again from Goldshield. Medical information on 08700 703033; stock enquiries on 020 8588 9273.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.